Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of antidiabetic drug on endothelial function

Trial Profile

Effect of antidiabetic drug on endothelial function

Phase of Trial: Phase II

Latest Information Update: 01 Aug 2018

At a glance

  • Drugs Linagliptin (Primary) ; Voglibose (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms EFFORT
  • Most Recent Events

    • 18 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
    • 19 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top